Dr. August is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 Gillham Rd.
Kansas City, MO 64108
Education & Training
- Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- University of Louisville School of MedicineResidency, Pediatrics, 2002 - 2005
- University of Oklahoma College of MedicineClass of 2002
Certifications & Licensure
- KS State Medical License 2011 - 2025
- MO State Medical License 2009 - 2025
- GA State Medical License 2005 - 2011
- OK State Medical License 2009 - 2010
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults Start of enrollment: 2015 Jul 01
- A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
- A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer Start of enrollment: 2016 Aug 29
Publications & Presentations
PubMed
- 12 citationsEarly Discharge of Neutropenic Pediatric Oncology Patients Admitted With Fever.Melanie A. Villanueva, Keith J. August
Pediatric Blood & Cancer. 2016-10-01 - 14 citationsChlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double-blinded randomized controlled trial from ...Danielle M. Zerr, Aaron M. Milstone, Christopher C. Dvorak, Amanda L. Adler, Lu Chen
Cancer. 2021-01-01 - 68 citationsBrentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.Franco Locatelli, Christine Mauz-Koerholz, Kathleen A. Neville, Anna Llort, Auke Beishuizen
The Lancet. Haematology. 2018-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: